MolNFT v1 · #142687 · protein
Crystal structure of mycobacterium tuberculosis mfd at 3.6 a resolution
6ACA: “Crystal structure of mycobacterium tuberculosis mfd at 3.6 a resolution”. X-ray diffraction, 16 pockets (best druggability 0.86). MolNFT v1 #142687 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6ACA
- Type
- protein
- Length
- 1,133 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Mycobacterium tuberculosis mfd
- EC
- 3.6.4.-
- UniProt
- P9WMQ5
- Pockets
- 16 · best druggability 0.86
Structure
x-ray diffraction · 1 distinct chain · 38% helix, 15% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Mycobacterium tuberculosis mfd (EC 3.6.4.-) | protein | 1133 | 38% helix, 15% strand | P9WMQ5 |
Pockets
16 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 943 | 0.86 | 0.88 | 107 | empty |
| 2 | 906 | 0.78 | 0.81 | 102 | empty |
| 3 | 233 | 0.74 | 0.88 | 35 | empty |
| 4 | 57 | 0.70 | 0.97 | 22 | empty |
| 5 | 552 | 0.68 | 0.78 | 54 | empty |
Compared structures
- 6ACA · Crystal structure of Mycobacterium tuberculosis Mfd at 3.6 A resolution · the same entry in another collection · chain A against A, TM-score 1.00
- P9WMQ5 · AlphaFold monomer V2.0 prediction for transcription-repair-coupling factor (P9WMQ5) · a predicted model of the same protein · chain A against A, TM-score 0.93
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P9WMQ5
- Elsewhere: RCSB PDB 6ACA · PDBe 6ACA · UniProt P9WMQ5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.